Teleflex Incorporated

TFX Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 28.9%, EPS fell 17.3%, free cash flow grew 220.1% and total debt rose 47.7%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years.

130.43 2.21 +1.72%
Market cap
$5.4B
P/E
0.0×
Fwd P/E
45.3×
Dividend yield
1.04%
F-score
5/9
Altman Z
2.04
Beneish M
−2.21
Dividend safety
20/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
4.45 2.73 2.49 2.45
P/FCF ratio
0.00 3,766.02 205.78 32.79
P/Operating CF
27.30 (59.01) 113.45 60.09
P/B ratio
1.42 1.74 1.72 1.90
EV/Sales
6.35 3.87 3.57 3.56
EV/EBITDA
43.44 25.63 29.13 31.34
EV/FCF
(218.49) 5,330.95 295.49 47.68
Current Ratio
2.57 2.54 2.55 2.60
Net Debt/EBITDA
17.56 (30.04) 30.61 20.20
Debt/Equity
0.70 0.85 0.85 0.97
Earnings Yield
(6.00%) (16.83%) (19.06%) (18.37%)
Free Cash Flow Yield
(0.65%) 0.03% 0.49% 3.05%
Free Cash Flow per Share
3.52 (2.08) 0.63 1.79
Book value per Share
86.40 70.03 69.69 66.68
Free Cash Flow
155.60 (92.94) 27.87 77.86
EV/EBIT
0.00 65.12 121.13 180.68
Other line items

Show all line items

Columns are period end dates · fundamentals updated 1 Oct 2026